Viewing Study NCT00619957


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-02-20 @ 10:09 PM
Study NCT ID: NCT00619957
Status: COMPLETED
Last Update Posted: 2011-10-28
First Post: 2008-02-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
Sponsor: Warner Chilcott
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 2001092 and 2001092 OL
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View